CDNF overexpression has also been boosted with a simultaneous gene delivery of aromatic L-amino acid decarboxylase (AADC), which is an enzyme involved in dopamine synthesis and has been shown to alleviate symptoms of PD patients in clinical trials (117). This evidence concerns the gene DDC and Parkinson disease.